Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bank Leumi, Gilat, Kardan, Teva: Israel Equity Preview

The following stocks may rise or fall in Israeli markets. Stock symbols are in parentheses after the company names and prices are from the close unless otherwise stated.

The TA-25 Index rose less than 0.1 percent to 1,263.13 in Tel Aviv.

Bank Leumi Le-Israel Ltd. (LUMI IT): Israel’s largest bank posted third-quarter net income of 603 million shekels ($164 million) compared with 534 million shekels a year earlier. Leumi increased 0.5 percent to 17.77 shekels.

Gilat Satellite Networks Ltd. (GILT IT): The developer of satellite network technology completed its acquisition of Wavestream Corp. for about $130 million. Gilat fell 0.7 percent to 17.99 shekels.

Kardan Israel Ltd. (KRIS IT): The real estate investment group’s third-quarter net income rose to 24.9 million shekels from a profit of 33.3 million shekels a year-earlier. Kardan rose 0.5 percent to 8.207 shekels.

Perrigo Inc. (PRGO IT): The manufacturer of over-the-counter pharmaceuticals said its licensor Synthon received final approval from the U.S. Food and Drug Administration for a generic version of Xyzal allergy tablets. Perrigo gained 0.3 percent to 228.5 shekels.

Teva Pharmaceutical Industries Ltd. (TEVA IT): The world’s largest maker of generic drugs’ strategic partner in the distribution of a generic version of Concerta tablets, Impax, is being sued by Alza Corp. for patent infringement in a U.S. District Court in Delaware. Teva rose 0.2 percent to 186.3 shekels.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.